This class of medications is widely used to relieve Parkinson’s disease, overactive bladder, and certain respiratory disorders. Their mechanism of action involves blocking acetylcholine, a neurotransmitter essential for learning and memory.
Prolonged blockade of this neurotransmitter has disastrous consequences for cognitive function. According to research conducted by the University of Washington that followed more than 3,500 elderly people over a decade, regular use of anticholinergics increases the risk of developing dementia by 54%. This risk increases proportionally with the dose and duration of treatment.
- Proton pump inhibitors (Omeprazole)
Omeprazole, pantoprazole, and esomeprazole are proton pump inhibitors (PPIs), widely used to relieve heartburn, acid reflux, and gastritis. While they offer rapid relief by reducing stomach acid, their chronic use poses alarming risks to neurological health .
A study of nearly 6,000 individuals revealed that 33% of patients taking these medications for more than four and a half years experienced cognitive impairment. This phenomenon is largely explained by the fact that reduced stomach acidity hinders the proper absorption of vitamin B12. Prolonged vitamin B12 deficiency is a known cause of severe neurological disorders and an increased risk of dementia.Food
- Benzodiazepines
Alprazolam, diazepam, and lorazepam are familiar names to anyone who has ever suffered from severe anxiety or insomnia. These anxiolytics and sleeping pills offer short-term relief, but their long-term impact on the brain is particularly significant.
Studies show that prolonged benzodiazepine use can double the risk of developing Alzheimer’s disease. These drugs interfere with neurotransmitters, alter sleep patterns (which are essential for memory consolidation), and create strong physical and psychological dependence. In fact, more than 40% of regular users report difficulty concentrating and a loss of mental energy.
- Amphetamines
